Upregulation of SOX2 is regarded as a pivotal event in SCLC, where the protein functions as a lineage-survival oncogene that contributes to the transcriptional deregulation observed in the disease and promotes the classical neuroendocrine phenotype [13,18]. This evidence concerns the gene SOX2 and small cell lung carcinoma.